Science Current Events | Science News | Brightsurf.com
 

Hypothermia remains effective in cardiac arrest patients with preexisting cardiomyopathy

November 15, 2011
Cardiomyopathy is common among cardiac arrest survivors. The survival and neuroprotective benefits of therapeutic hypothermia is similar in patients with preexisting cardiomyopathy, compared with those patients without cardiomyopathy, according to a scientific poster being presented Nov. 14 at the at the American Heart Association (AHA) scientific sessions in Orlando, Fla. Therefore, the researchers recommended the use of therapeutic hypothermia in patients with the preexisting condition.

"While it is well established that therapeutic hypothermia is neuroprotective and increases survival in resuscitated cardiac arrest patients without cardiomyopathy, we sought to determine whether catastrophic outcomes in cardiac arrest patients with preexisting cardiomyopathy are avoidable," said Michael R. Mooney, MD, a cardiologist at the Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis and physician researcher with Minneapolis Heart Institute Foundation.

From February 2006 to July 2010, Mooney and his colleagues enrolled 192 consecutive cardiac arrest patients who remained unresponsive following return of spontaneous circulation in a therapeutic hypothermia protocol, regardless of initial rhythm, hemodynamic status or prior medical history. They hypothesized that there would be a high prevalence of preexisting cardiomyopathy in this patient population, and therapeutic hypothermia would confer similar neurologic and survival benefit compared to non-cardiomyopathy patients.

Of the 192 patients, 43.8 percent had preexisting cardiomyopathy, of which ischemic was the most common type (41.7 percent). Patients with preexisting cardiomyopathy were older (65.7 years vs. 61.7 years) and more likely to be male (83.3 vs. 63.9 percent).

The majority presented in ventricular fibrillation/ventricular tachycardia (75 percent and 70.4 percent) in both the cardiomyopathy and non-cardiomyopathy groups. There was a higher prevalence of concurrent STEMI in the cardiomyopathy group (27 vs. 18.5 percent), which was not statistically significantly. Cardiogenic shock was more prevalent in the cardiomyopathy group (54.8 vs. 28.7 percent).

While the cardiomyopathy groups were slightly higher, the survival between the two groups (52.4 vs. 51.9 percent) and survival with favorable neurologic outcome, defined by Cerebral Performance Category 1 or 2, (46.4 vs. 49.1 percent), were similar. They found that survival with favorable neurologic outcome in cardiomyopathy patients with cardiogenic shock was 34.8 percent, compared with 45.2 percent in non-cardiomyopathy cardiogenic shock patients.

"The incidence of preexisting heart dysfunction in this observational study is alarming. In general, we need to employ a more careful surveillance and improve our adherence to the clinical guidelines, as less than 50 percent of patients who currently qualify for automatic implantable cardioverter-defibrillators actually receive them," Mooney said. "A great deal more research is warranted in assessing this patient population."

Minneapolis Heart Institute Foundation


Related Cardiomyopathy Current Events and Cardiomyopathy News Articles


Two Michigan high school students develop screening tools to detect lung and heart disease
Two Michigan high school students, sisters Ilina and Medha Krishen, have developed screening tools using electronic stethoscopes to detect lung and heart disease. The sisters will present their findings at CHEST 2014 in Austin, Texas next week.

Metabolic Genetics Research Paves Way to Treating Diabetes and Obesity
Breaking down complex conditions such as Type 2 Diabetes and obesity into the specific metabolic proteins and processes that underlie them offers a new approach to studying the genetics of these diseases and how they are interrelated, according to research presented today at the American Society of Human Genetics (ASHG) 2014 Annual Meeting in San Diego.

Vitamin E intake critical during 'the first 1,000 days'
Amid conflicting reports about the need for vitamin E and how much is enough, a new analysis published today suggests that adequate levels of this essential micronutrient are especially critical for the very young, the elderly, and women who are or may become pregnant.

Earlier intervention for common form of heart attack linked to improved survival
Changes in the treatment of the most common form of heart attack over the past decade have been associated with higher survival rates for men and women regardless of age, race and ethnicity, according to a UCLA-led analysis.

Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors
A St. Jude Children's Research Hospital study found that 73 percent of adult survivors of childhood cancer more than doubled their risk of developing metabolic syndrome and related health problems by failing to follow a heart-healthy lifestyle.

First evidence for painless atrial fibrillation treatment
The first evidence for a shockless treatment for atrial fibrillation (AF) will be presented today at Frontiers in CardioVascular Biology (FCVB) 2014 in Barcelona, Spain.

New report offers a primer for doctors' use of clinical genome and exome sequencing
Sooner than almost anyone expected, a new, genome-based technology for demystifying undiagnosed illnesses-particularly rare childhood diseases-is moving from research laboratories into general medical practice.

Zebrafish model helps identify compound that reverses a lethal form of cardiomyopathy
Using a zebrafish model, investigators have identified a drug compound that appears to reverse arrhythmogenic cardiomyopathy (ACM), a hereditary disease and leading cause of sudden death in young people.

Biomarker test for Peripartum Cardiomyopathy could help reduce death after giving birth
Cardiologists have discovered biomarkers that can be used to develop a screening test to detect Peripartum Cardiomyopathy (PPCM), a life-threatening disorder that is the primary cause of mortality in pregnant women in developing countries.

Research shows hope for normal heart function in children with fatal heart disease
After two decades of arduous research, a National Institutes of Health (NIH)-funded investigator at the Children's Hospital of Michigan (CHM) at the Detroit Medical Center (DMC) and the Wayne State University School of Medicine has published a new study showing that many children with an often fatal type of heart disease can recover "normal size and function" of damaged sections of their hearts.
More Cardiomyopathy Current Events and Cardiomyopathy News Articles

A Guide to Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians

A Guide to Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians
by Barry J. Maron (Author), Lisa Salberg (Author)


Written by the authority on hypertrophic cardiomyopathy (HCM) and an HCM patient, and fully endorsed by the Hypertrophic Cardiomyopathy Association (HCMA), the leading advocacy and support organization, the 3rd Edition of this best-selling guide offers unparalleled insight into all aspects of living with and treating HCM.Accessible and practical, A Guide to Hypertrophic Cardiomyopathy For Patients, Their Families and Interested Physicians 3rd Edition:Answers the most pressing questions posed by patients, their families, and non-specialists
health professionals involved in their careCovers everything from what is HCM and initial diagnosis of this increasingly prevalent
condition to the latest treatment optionsReflects the first-ever HCM guidelines published by the American Heart...

Don't Take Heart Transplant For an Answer - Cardiomyopathy Treatment Action Plan

Don't Take Heart Transplant For an Answer - Cardiomyopathy Treatment Action Plan


Studies show that of all the organs in the human body, the heart is by far the most receptive to nutritional treatment.

After watching my son go to the cardiologist repeatedly and never seeing considerable improvement for his dilated cardiomyopathy, they were suggesting that a heart transplant would ultimately be the solution. I wasn’t about to simply stand by without researching as much as I could to help him. He had an ejection fraction of just 15%. A normal reading for this is 55% to 65%.

"Don't Take Heart Transplant for an Answer - Cardiomyopathy Treatment Action Plan" provides in-depth details about a congestive heart failure action plan that is relevant to the various types of cardiomyopathy, such as dilated, hypertrophic and restrictive...

Complete Medical Guide and Prevention for Heart Disease Volume IX; Cardiomyopathy

Complete Medical Guide and Prevention for Heart Disease Volume IX; Cardiomyopathy
by MedHealth


Heart is a muscular organ that located the center of the circulatory system. It pumps blood throughout body via blood vessels network, such as capillaries, arteries and veins. Blood is delivered to and from all parts of body by these blood vessels.

At the optimal rate required to function well, a healthy heart provides your entire body with the proper quantity of blood. If disease or injury impairs your heart, your body's organs won't obtain enough blood to operate regularly.

Cardiopathy, commonly known as cardiac disease or heart disease, is an hyponym for a various diseases affecting the heart. Since 2007, it is one of the major cause of death in the United States, Canada and some European countries such as England and Wales, representing about 25.4% of the total...

Cardiomyopathies: Causes, Effects and Treatment

Cardiomyopathies: Causes, Effects and Treatment
by Peter H. Bruno (Author), Peter H. Bruno (Editor), Matthew T. Giordano (Editor)


Cardiomyopathy is a type of heart disease in which the heart becomes abnormally enlarged, thickened and/or stiffened. As a result, the heart muscle's ability to pump and/or receive blood is impaired. This book describes the most recent advances in cardiomyopathies- one of the leading causes of hospitalisation worldwide. Dilated cardiomyopathy (DCM), also known as congestive cardiomyopathy, is a condition in which the heart becomes weakened and enlarged, and as a result, cannot pump blood efficiently. The causes, effects, as well as the severity of DCM are described in this book, as well as the types of therapy that are effective, such as anti-inflammatory or immunosuppressive therapy. There has been a general decrease of cardiac involvement in HIV-positive subjects in recent years due...

Success with Heart Failure (mass mkt ed): Help and Hope for Those with Congestive Heart Failure

Success with Heart Failure (mass mkt ed): Help and Hope for Those with Congestive Heart Failure
by Marc Silver (Author)


Up-to-date information on available and forthcoming medical and surgical treatments. How attitude and emotion affect heart failure-and what you can do to stay positive. Tips for adopting a heart-healthy diet and lifestyle. Ways to forge a positive wo

Current Concepts in Arrhythmogenic Right Ventricular Cardiomyopathy / Dysplasia

Current Concepts in Arrhythmogenic Right Ventricular Cardiomyopathy / Dysplasia
by Corinna Brunckhorst (Author), Corinna Brunckhorst (Editor), Firat Duru (Editor), Ardan M. Saguner (Editor)


Edited and written by internationally recognized authorities, Current Concepts in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D) presents important insights to all aspects of this unique disease and will serve as a valuable guide to help readers provide the best possible care for their patients. Discussion of ARVC/D by the experts includes:
Basic and clinical science. Pathophysiology, molecular mechanisms, and genetic background. The mechanisms of disease progression leading to a diversity of disease phenotypes. Challenges in the clinical setting with respect to diagnosis, risk stratification, and therapy.

"The editors...have enlisted as authors those who first recognized and named the disease, and most of those responsible for the recent advances in this...

Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians

Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians
by Barry J. Maron (Author), Lisa Salberg (Author)


When there is a diagnosis of HCM in a family, this complete, easy-to-read guide is your essential resource for finding the answers to your many questions. In clear and straightforward language, it explains what hypertrophic cardiomyopathy is, what the symptoms are, and how it can be treated, as well as reviewing the genetic implications and offering candid lifestyle advice. Drawing on the expertise of Dr. Barry Maron, an internationally recognized authority on HCM, the book addresses major questions and concerns of both patients and families. Fully revised to reflect the latest developments, Hypertrophic Cardiomyopathy: For patients, their families and interested physicians, Second Edition, is a valuable source of straightforward advice and dependable information for everyone who is...

Cardiomyopathy

Cardiomyopathy
by Thomas D. Giles (Author), Gary E. Sander (Editor)


Book in good condition overall. Has minor edge, shelf, or handling wear. Light wear at spine and edges/showing evident of rubbed near spine. Light surface tear on front cover page from removing price sticker. Tight binding. Clean pages.

Hypertrophic Cardiomyopathy: Foreword by Bernard Gersh and Historical Context by Eugene Braunwald

Hypertrophic Cardiomyopathy: Foreword by Bernard Gersh and Historical Context by Eugene Braunwald
by Srihari Naidu (Editor)


This book provides a comprehensive clinical review of Hypertrophic Cardiomyopathy (HCM), the most common genetic disorder of the heart characterized by dysfunctional contractility at the sarcomere level, resulting in the development of abnormal and occasionally focal hypertrophy on a macroscopic level. Editor, Srihari S. Naidu, has brought together a world renowned group of experts to review various different topics but, with a practical focus that will enable readers to establish the evidence-based best practice in any potential scenario. Treatment modalities including medications, pacemakers and defibrillators, and invasive septal reduction therapy (both surgical myectomy and alcohol septal ablation) will be discussed. Chapters on genetics, family screening, lifestyle concerns, and...

Netter's Cardiology Volume 2: III. Myocardial Diseases and Cardiomyopathy; IV. Cardiac Rhythm Abnormalities

Netter's Cardiology Volume 2: III. Myocardial Diseases and Cardiomyopathy; IV. Cardiac Rhythm Abnormalities
by Marschall Runge (Author)




© 2014 BrightSurf.com